Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125423312 | 12542331 | 2 | F | 20160411 | 20160831 | 20160708 | 20160908 | EXP | CO-ASTRAZENECA-2016SE58483 | ASTRAZENECA | 15854.00 | DY | F | Y | 66.00000 | KG | 20160909 | CO | CO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125423312 | 12542331 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 35000 | MG | 0 | 250 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125423312 | 12542331 | 1 | Lung neoplasm malignant |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125423312 | 12542331 | OT |
125423312 | 12542331 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125423312 | 12542331 | Death | |
125423312 | 12542331 | Drowning | |
125423312 | 12542331 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125423312 | 12542331 | 1 | 20160411 | 0 |